We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sleep Disordered Breathing and Diabetes

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00901472
First Posted: May 13, 2009
Last Update Posted: September 5, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Chicago
  Purpose

The hypothesis of this study is: sleep disordered breathing (SDB), specifically, obstructive sleep apnea, is associated with poorer glucose in the existing type 2 diabetic condition.

In an exploration of this hypothesis, the investigators hope to provide evidence linking SDB to increased severity of disease in the type 2 diabetic patient. By doing so, the investigators ultimately seek to support investigating the use of SDB interventions as an additional method of care in the treatment of type 2 diabetes.


Condition
Type 2 Diabetes Obstructive Sleep Apnea

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Sleep Disordered Breathing and Blood Glucose Control in Type 2 Diabetes

Resource links provided by NLM:


Further study details as provided by University of Chicago:

Primary Outcome Measures:
  • Improvement in glucose tolerance [ Time Frame: Day 1 to day 10. ]

Biospecimen Retention:   None Retained
Blood was taken for HbA1C

Enrollment: 105
Study Start Date: February 2007
Study Completion Date: December 2009
Primary Completion Date: November 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts
Stable type 2 Diabetes (ST2D)
Adults with Type 2 diabetes who receive medical care at the University of Chicago

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Adult female and male patients with type 2 diabetes who are followed by University of Chicago physicians in the endocrinology or primary care clinic will self-identify themselves for participation in response to flyers posted at the check-in desk.
Criteria

Inclusion Criteria:

  • adult female and male patients with type 2 diabetes who are followed by University of Chicago physicians

Exclusion Criteria:

  • patients with the diagnosis of type 1 diabetes (DM); newly diagnosed Type 2 DM patients
  • patients with the diagnosis of OSA using CPAP for either 4 or more hours per night or 5 nights per week
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00901472


Locations
United States, Illinois
The University of Chicago
Chicago, Illinois, United States, 60637
Sponsors and Collaborators
University of Chicago
Investigators
Principal Investigator: Eve Van Cauter, PhD University of Chicago
  More Information

Responsible Party: University of Chicago
ClinicalTrials.gov Identifier: NCT00901472     History of Changes
Other Study ID Numbers: #14903B
First Submitted: May 11, 2009
First Posted: May 13, 2009
Last Update Posted: September 5, 2013
Last Verified: September 2013

Keywords provided by University of Chicago:
Type 2 diabetes,
obstructive sleep apnea

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Sleep Apnea Syndromes
Sleep Apnea, Obstructive
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Apnea
Respiration Disorders
Respiratory Tract Diseases
Sleep Disorders, Intrinsic
Dyssomnias
Sleep Wake Disorders
Nervous System Diseases